Your pancreas secretes the hormones glucagon and insulin to regulate blood sugar by signaling your liver to break down fat into sugar (glucagon) or to store sugar as fat (insulin). These hormones work as a pair to maintain homeostasis, and they stimulate the release of each other through a complex feedback mechanism. While THC primarily increases glucagon and blood sugar, CBD lowers insulin levels, and it is this CBD action that helps to explain why marijuana users tend to eat more calories but do not gain any extra weight, have less obesity and have lower rates of type II diabetes than non-users, and is also why some diabetics find that marijuana makes it easier to manage their blood sugar.
CBD oil’s role in cancer treatment still needs more research, but what is available is looking promising. According to the American Cancer Society, CBD oil can slow growth and spread of some kinds of cancer (in animals). Because it fights oxidative stress and inflammation (and both are linked to cancer) it makes sense that CBD oil could help fight cancer cells.
Thanks to research and modern technology the cannabis plant is now being processed in numerous ways to help patients from across the world. Patients are able to benefit of it’s cannabinoids CBD and THC in the form of oils. One of those ways is in the form of CBD Oil. To create CBD oil, solvents, such as CO2 are used to separate the cannabinoids (in the form of oils) from the plant material, creating the highly concentrated product.
Hemp-based CBD, on the other hand, is most often sourced from legal industrial hemp plants that contain very small amounts of THC. This type of CBD can be grown under the United States Farm Bill. If you are going to be buying oils for anxiety from an online seller, for example, then you will likely be purchasing a product that has been sourced from hemp, rather than marijuana. This is perfectly fine, because even though industrial hemp lacks the mind-altering THC compound, it contains functional amounts of CBD.
In the United States, non-FDA approved CBD products are classified as Schedule I drugs under the Controlled Substances Act. This means that production, distribution, and possession of non-FDA approved CBD products is illegal under federal law. In addition, in 2016 the Drug Enforcement Administration added "marijuana extracts" to the list of Schedule I drugs, which it defined as "an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant." Previously, CBD had simply been considered "marijuana", which is a Schedule I drug.